[go: up one dir, main page]

BR9916190A - Emprego de inibidores do canal kqt1 para a preparação de um medicamento para o tratamento de doenças, que são provocadas por helmintos e ectoparasitas - Google Patents

Emprego de inibidores do canal kqt1 para a preparação de um medicamento para o tratamento de doenças, que são provocadas por helmintos e ectoparasitas

Info

Publication number
BR9916190A
BR9916190A BR9916190-7A BR9916190A BR9916190A BR 9916190 A BR9916190 A BR 9916190A BR 9916190 A BR9916190 A BR 9916190A BR 9916190 A BR9916190 A BR 9916190A
Authority
BR
Brazil
Prior art keywords
ectoparasites
helminths
kqt1
medicine
preparation
Prior art date
Application number
BR9916190-7A
Other languages
English (en)
Inventor
Uwe Gerlach
Joachim Hofmann
Hans Jochen Lang
Aguan Wei
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of BR9916190A publication Critical patent/BR9916190A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

Patente de Invenção: <B>"EMPREGO DE INIBIDORES DO CANAL KQT1 PARA A PREPARAçãO DE UM MEDICAMENTO PARA O TRATAMENTO DE DOENçAS, QUE SãO PROVOCADAS POR HELMINTOS E ECTOPARASITAS"<D>. A invenção refere-se a inibidores do canal KQT1 que representam um novo princípio letal para helmintos e ectoparasitas. Por isso, utilizam-se bloqueadores do canal KQT1 celular, que aparece em helmintos e ectoparasitas, para preparar um medicamento para o tratamento de animais vertebrados e homem, que são infestados por helmintos ou ectoparasitas. Estes bloqueadores KQT1 são aplicados como medicamentos sozinhos ou em combinação com outros medicamentos e medidas terapêuticas. Inibidores do canal KQT1 representam igualmente um novo mecanismo de ação para as pragas de plantas tais como insetos, tetrânicos, moluscos e nematódios e são empregados, conseq³entemente, para a preparação de um agente de proteção de plantas.
BR9916190-7A 1998-12-17 1999-12-07 Emprego de inibidores do canal kqt1 para a preparação de um medicamento para o tratamento de doenças, que são provocadas por helmintos e ectoparasitas BR9916190A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19858253A DE19858253A1 (de) 1998-12-17 1998-12-17 Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden
PCT/EP1999/009547 WO2000035429A1 (de) 1998-12-17 1999-12-07 Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden

Publications (1)

Publication Number Publication Date
BR9916190A true BR9916190A (pt) 2001-09-11

Family

ID=7891421

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9916190-7A BR9916190A (pt) 1998-12-17 1999-12-07 Emprego de inibidores do canal kqt1 para a preparação de um medicamento para o tratamento de doenças, que são provocadas por helmintos e ectoparasitas

Country Status (24)

Country Link
US (2) US6335363B1 (pt)
EP (1) EP1140042B1 (pt)
JP (1) JP2002532412A (pt)
KR (1) KR20010089574A (pt)
CN (1) CN1170528C (pt)
AR (1) AR021690A1 (pt)
AT (1) ATE390130T1 (pt)
AU (1) AU1559500A (pt)
BR (1) BR9916190A (pt)
CA (1) CA2355300A1 (pt)
CZ (1) CZ20012125A3 (pt)
DE (2) DE19858253A1 (pt)
HK (1) HK1041647B (pt)
HR (1) HRPK20010442B1 (pt)
HU (1) HUP0200152A3 (pt)
IL (1) IL143717A0 (pt)
NO (1) NO20012976L (pt)
NZ (1) NZ512408A (pt)
PL (1) PL349511A1 (pt)
RU (1) RU2238090C2 (pt)
SK (1) SK8562001A3 (pt)
TR (1) TR200101750T2 (pt)
WO (1) WO2000035429A1 (pt)
ZA (1) ZA200103620B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1718677T3 (da) * 2003-12-19 2012-07-09 Genentech Inc Monovalente antistoffragmenter egnede som terapeutiske midler
RU2398777C2 (ru) * 2004-08-05 2010-09-10 Дженентек, Инк. ГУМАНИЗИРОВАННЫЕ АНТАГОНИСТЫ, НАПРАВЛЕННЫЕ ПРОТИВ c-met
EP2687093B1 (en) * 2006-09-01 2020-07-22 FMC Corporation Local topical administration formulations containing indoxacarb
DK2883545T3 (en) 2007-06-07 2018-11-05 Bayer Animal Health Gmbh Control of ectoparasites
RU2364432C1 (ru) * 2008-03-21 2009-08-20 Олег Николаевич Моисеев Способ лечения глистных инвазий
US20100307542A1 (en) * 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Method of Reducing Surface Oil on Encapsulated Material
US20100310726A1 (en) 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Novel Preparation of an Enteric Release System
US8859003B2 (en) * 2009-06-05 2014-10-14 Intercontinental Great Brands Llc Preparation of an enteric release system
US9968564B2 (en) * 2009-06-05 2018-05-15 Intercontinental Great Brands Llc Delivery of functional compounds
CN107090038A (zh) 2011-06-30 2017-08-25 霍夫曼-拉罗奇有限公司 抗c‑met抗体配制剂
US8859005B2 (en) 2012-12-03 2014-10-14 Intercontinental Great Brands Llc Enteric delivery of functional ingredients suitable for hot comestible applications
KR20160137599A (ko) 2014-03-24 2016-11-30 제넨테크, 인크. C-met 길항제로의 암 치료 및 이것과 hgf 발현과의 상관관계
EP2957557A1 (en) * 2014-06-17 2015-12-23 Novartis Tiergesundheit AG New compounds
MY196648A (en) 2016-02-05 2023-04-27 Denali Therapeutics Inc Inhibitors of Receptor-Interacting Protein Kinase 1
CN110383066B (zh) 2016-12-09 2023-03-31 戴纳立制药公司 化合物、组合物和方法
PE20200608A1 (es) * 2017-06-30 2020-03-10 Bayer Animal Health Gmbh Nuevos derivados de azaquinolina
AU2023206890A1 (en) 2022-01-12 2024-08-22 Denali Therapeutics Inc. Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ276577A (en) * 1993-11-29 1997-11-24 Merrell Pharma Inc 2-acyl-4-benzenesulphonyliminoquinoline and -chromene derivatives
US5559026A (en) * 1994-10-31 1996-09-24 American Cyanamid Company Genes encoding a novel family of potassium channels
DE19504379A1 (de) * 1995-02-10 1996-08-14 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate sowie sie enthaltende pharmazeutische Präparate
EP0807629B1 (de) 1996-05-15 2004-03-03 Aventis Pharma Deutschland GmbH Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
NZ329200A (en) * 1996-12-16 1999-05-28 Hoechst Ag Sulphonamide substituted quinazoline, isoquinoline, quinoline or benzo[1,3-]oxazine derivatives and medicaments
DE19706675A1 (de) 1997-02-20 1998-08-27 Hoechst Ag Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19707656A1 (de) 1997-02-26 1998-08-27 Hoechst Ag Sulfonamid-substituierte anellierte 7-Ring-Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
DE19742509A1 (de) 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
DE19742508A1 (de) 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
DE19748469A1 (de) * 1997-11-03 1999-05-06 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
ZA200103620B (en) 2002-06-04
CZ20012125A3 (cs) 2001-09-12
AU1559500A (en) 2000-07-03
TR200101750T2 (tr) 2002-01-21
US6335363B1 (en) 2002-01-01
HK1041647B (zh) 2005-04-01
CN1170528C (zh) 2004-10-13
HRPK20010442B1 (en) 2003-10-31
NO20012976L (no) 2001-08-06
SK8562001A3 (en) 2001-12-03
KR20010089574A (ko) 2001-10-06
JP2002532412A (ja) 2002-10-02
HUP0200152A2 (hu) 2002-05-29
CA2355300A1 (en) 2000-06-22
PL349511A1 (en) 2002-07-29
HRP20010442A2 (en) 2002-06-30
EP1140042B1 (de) 2008-03-26
DE59914712D1 (de) 2008-05-08
ATE390130T1 (de) 2008-04-15
EP1140042A1 (de) 2001-10-10
US20020055537A1 (en) 2002-05-09
NO20012976D0 (no) 2001-06-15
CN1330540A (zh) 2002-01-09
DE19858253A1 (de) 2000-06-21
RU2238090C2 (ru) 2004-10-20
HUP0200152A3 (en) 2003-01-28
NZ512408A (en) 2003-10-31
IL143717A0 (en) 2002-04-21
WO2000035429A1 (de) 2000-06-22
AR021690A1 (es) 2002-07-31
HK1041647A1 (en) 2002-07-19

Similar Documents

Publication Publication Date Title
BR9916190A (pt) Emprego de inibidores do canal kqt1 para a preparação de um medicamento para o tratamento de doenças, que são provocadas por helmintos e ectoparasitas
UY26130A1 (es) Compuestos para tratar la obesidad
BR0307356A (pt) Misturas inseticidas sinergìsticas
CY1111912T1 (el) Μεθοδος αναστολης της δραστηριοτητας των οστεοκλαστων
BRPI0607897A2 (pt) compostos oxindol e sua utilização como agentes terapêuticos
BR9914638A (pt) Composto, método para a preparação do mesmo, composição farmacêutica, uso de um composto, e, método para o tratamento de um distúrbio ou doença de um corpo de animal vivo
BR0317747A (pt) Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave
AR030068A1 (es) Composiciones farmaceuticas para el tratamiento de condiciones dolorosas, inflamatorias y ulcerosas de superficies epiteliales humedas como por ejemplo mucositis, estomatitis y sindrome de behcet
BR0108427B1 (pt) composiÇço contendo misturas de substÂncias ativas com propriedades inseticidas e acaricidas, sua aplicaÇço e seu processo de preparaÇço, bem como processo para combater pragas animais.
BRPI0418099A (pt) compostos, composição farmacêutica, e uso de um composto
BR9710617A (pt) Composição pesticida e método de utilização
DE60232077D1 (de) Verwendung mindestens einer glycoinhibitor-substanz gegen infektionskrankheiten
BR0313239A (pt) Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de doenças
BR0001291A (pt) Desfolhante
BR0010983A (pt) Preparações para a aplicação de agentes antiinflamatórios
ATE253904T1 (de) Verwendung von pharmazeutische zusammensetzungen enthaltend thymol und/oder carvacrol in der behandlung von histomoniasis
BR0307834A (pt) Misturas inseticidas sinergìsticas
BR0209430A (pt) Compostos heterocìclicos
UY27451A1 (es) 2,5-diamidoindoles sustituidos y su utilización
BR0014610A (pt) Combinações de compostos ativos tendo propriedades inseticidas e acaricidas
BR0210401A (pt) Composto, composição farmacêutica, uso de um composto e método para o tratamento de um distúrbio ou de uma doença de um corpo de animal vivo, incluindo um humano
AR028987A1 (es) Compuesto derivado de ciclopentapiridin-cetona, composicion farmaceutica que lo contiene y su uso en la fabricacion de un medicamento util para tratar una enfermedad
DE60217292D1 (de) Veterinärmedizinische dermatologische zusammensetzung
BR9913990A (pt) Uso de compostos organofosforados para a produção de preparações farmacêuticas para o tratamento terapêutico e profilático de infecções ou como um fungicida, bactericida ou herbicida em plantas
BR0015781A (pt) Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH (DE)

Free format text: ALTERADO DE: AVENTIS PHARMA DEUTSCHLAND GMBH

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE ACORDO COM O ARTIGO 22 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.